Abbreviations: ASL = arterial spin labeling; BMI = body mass index; BOLD = blood oxygen leveldependent; BP = blood pressure; CAD = coronary artery disease; CIMT = carotid intimamedia thickness; CT = computed tomography; D = dimensional; DCE = dynamic contrastenhanced; DTI = diffusion tensor imaging; DWI = diffusion-weighted imaging; DXA = dualenergy x-ray absorptiometry; FDG = fluorodeoxyglucose; GFR = glomerular filtration rate; HU = Hounsfield units; IMCL = intramyocellular lipid; IVUS = intravascular ultrasound; LV = left ventricle; LVH = left ventricular hypertrophy; MetS = metabolic syndrome; MRE = magnetic resonance elastography; MRI = magnetic resonance imaging; MRS = magnetic resonance spectroscopy; MTI = magnetization-transfer imaging; NAFLD = non-alcoholic fatty liver disease; NAFPD = non-alcoholic fatty pancreatic disease; NASH = non-alcoholic steatohepatitis; OCT = optical coherence tomography; PET = positron emission tomography; PWV = pulse wave velocity; SAT = subcutaneous adipose tissue; SPECT = -photon emission computed tomography; TCD = transcranial Doppler; US = ultrasonography; VAT = visceral adipose tissue
INTRODUCTION
Metabolic syndrome (MetS) is the constellation of metabolic risk factors that might foster development of type 2 diabetes and cardiovascular disease. According to the NCEP-ATPIII 2005, 3 or more of the following 5 traits define MetS: (1) abdominal obesity by waist circumference; (2) elevated triglyceride levels or drug treatment for elevated triglycerides; (3) low levels of high-density lipoproteins or drug treatment for low high-density lipoproteins cholesterol; (4) elevated blood pressure (BP) or drug treatment for elevated BP; and (5) elevated fasting glucose or drug treatment for elevated blood glucose. These traits might be inter-related; therefore, whether MetS merely reflects the additive effects of the individual traits or stratifies distinct risk of cardiovascular disease remains controversial.
Abdominal obesity and insulin resistance play a particularly prominent role among all metabolic traits of the MetS. 1 Duration and severity of obesity are positively associated with incident MetS, as well as increased risk for other MetS components, suggesting that metabolically healthy obesity is a transient state in the pathway to cardiometabolic disease. 2 Obesity leads to increased morbidity including cardiovascular disease and type 2 diabetes, 3, 4 and is significantly correlated with increased mortality. 5, 6 Interventions and lifestyle modifications have been shown to reduce morbidity and mortality in MetS. 7, 8 Obesity, especially abdominal obesity, can also instigate or worsen insulin resistance in MetS. Excessive fatty acids in MetS increase lipid accumulation, inhibit insulin-mediated glucose uptake, and thereby reduce insulin sensitivity in several organs including adipose tissue, skeletal muscle, and liver. 9 Additionally, insulin resistance affects sodium reabsorption, sympathetic nervous system activation, and nitric oxide bioavailability, and is thus implicated in target organ injury. 10 Therefore, the ability to detect and monitor development and progression of abdominal obesity and insulin resistance and their consequences in target organs is important to stratify the risk and apply effective preventive and therapeutic intervention in individuals with MetS.
Recent advances in imaging modalities have provided significant insight into understanding the pathogenesis of 2 major components of MetS, abdominal obesity and insulin resistance. In addition, diagnostic imaging is essential for early detection of target organ injury and characterization of complications of MetS.
The purpose of this review is to summarize advances in diagnostic imaging modalities in MetS that can be applied for evaluating the features of MetS and its target organs. Timely use of imaging modalities may help in the diagnosis, prediction of target organ injuries, and development of novel therapeutic targets to alleviate and avert them.
The imaging methods used for quantification of adipose tissue include dual-energy x-ray absorptiometry (DXA). DXA measures the attenuation of 2 x-ray photon energies to distinguish fat, lean, and bone mineral content measures with low radiation exposure (~1 mSv/scan 16 ), short scanning time (5-13 minutes), high precision, and low cost. 17 DXA estimation of fat tissue may be somewhat influenced by the degree of hydration or edema. 18 Although it does not discriminate between VAT and SAT, recent studies have developed algorithms for segmenting fat within the torso. 19, 20 DXA-measured VAT shows a good correlation with CT-measured VAT volume (r 2 = 0.89-0.96 for females and 0.84-0.95 for males) 19, 20 and may provide clinically useful information to determine cardiometabolic risk. 21 However, intra-and interinstrument reliability of DXA remains imperfect. 22 US has been used to measure VAT and SAT using reflection of sound waves from tissue. 23 Although it is safe, noninvasive, applicable, fast, and relatively inexpensive, US requires experienced operators and considerable skill, and lacks standardized and reproducible methods for objective assessment of VAT. 24 To measure VAT, intraabdominal thickness 25 and abdominal fat index (ratio of the thicknesses of the pre-peritoneal and subcutaneous abdominal fat) 26 have been used. US VAT measurements have been validated against MRI or CT in obese adults and elderly, showing good correlations (r = 0.81-0.82), 25, 27 whereas SAT measures showed weaker correlations (r = 0.54-0.68). 25, 28 VAT indices measured by US were also correlated positively with serum triglyceride levels and inversely with high-density lipoprotein. 29 These results suggest that US may be useful in evaluating intra-abdominal adipose tissue.
CT is considered the reference standard for assessing SAT and VAT (Fig 2, A) . In CT, x-ray attenuation of tissue is expressed in Hounsfield units (HU), where 0 is assigned to water and −1000 is assigned to air. The values of adipose tissue density conventionally vary from −30 to −190 HU. CT can accurately assess VAT with excellent resolution of adipose tissue and at a relatively high speed. 30 To curtail ionizing radiation, VAT can be measured at L4 level in a single slice, which requires only 1 mSV, or 10% of the radiation dose in the standard abdominal-pelvis CT, 31 and is significantly correlated with the total abdominal VAT measured on a multislice CT scan (r = 0.94). 32 A recent study suggests a single-slice CT scan in late expiration for accurate measurement of VAT. The downward movement of the diaphragm during inspiration results in the compression of the abdominal cavity and extension of visceral fat, which cause overestimation of VAT and inclusion of the lower part of the kidney in the slice. 32 The importance of CT-based adiposity indices was confirmed in the recent study, which showed a significant correlation between VAT and cardiovascular disease even after adjustment for clinical risk factors and body mass index (BMI), whereas SAT showed no such correlation. 33 Overall, CT shows excellent reproducibility and repeatability of abdominal SAT and VAT measurement. 34 Several MR methods can also be used for imaging abdominal obesity, including relaxation-based (T1-weighted fast spin-echo sequence), phase-sensitive (chemical shift), and fat-selective MRI. 11, 35 MR offers the advantage of no radiation exposure, but has been used less frequently because of higher cost. Nevertheless, fat assessment using MR is useful for simultaneous evaluation of other cardiovascular risk factors in MetS. Fat and lean tissues have , respectively). Both visceral fat (yellow) and subcutaneous fat (red) were elevated in the obese subject. (B) Representative R2* maps obtained in lean and obese swine using blood oxygen level-dependent magnetic resonance imaging. Increasing orange and red colors indicate higher R2*, and in turn lower myocardial oxygenation. (C) Three-dimensional reconstructed CT images demonstrating increased perirenal fat (yellow) in obese swine. different longitudinal and transverse relaxation times (T1 and T2) in MRI. Fat has the lowest T1 (approximately 300 ms), but comparable T2 with other parenchyma organs (about 1000 ms for most water-containing tissues). 11, 36 Therefore, T1-weighted fast spin-echo sequence has been applied for quantification of fat, which exhibits high signal intensity. 37 This sequence provides a fast and reliable quantification of total body adipose tissue and the distribution of SAT and VAT. 37 In phasesensitive MRI, a frequency difference between water protons and methylene protons (the dominant fat peak) renders phase shift in-phase or opposed phase. 11 Fat selective MRI can be performed using suppression of the water signal by a frequency selective prepulse, by frequency selective excitation of the fat signal, or by spectral spatial excitation. 11 These images allow discriminations of fat from other tissues. VAT and SAT measures in MR significantly correlate with those of CT. 38 In addition, MRI-measured fat volumes showed an association with various anthropometric and biochemical parameters. 39 Given the little associated risk, MRI can also be used for longitudinal monitoring of changes in abdominal compartments during weight loss.
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Insulin resistance. Insulin resistance is a key feature in MetS. Skeletal muscle is a primary site for lipid and glucose metabolism responding to insulin, and plays an important role in the pathogenesis of insulin resistance. Excessive fatty acids in MetS increase lipid accumulation, inhibit insulin-mediated glucose uptake, and thereby reduce insulin sensitivity in skeletal muscle, 9 often preceding hyperglycemia and type 2 diabetes. 41 Therefore, imaging studies in skeletal muscle could be valuable for early detection of insulin resistance in MetS.
In muscle biopsy, intramyocellular lipid (IMCL) contents are inversely correlated with insulin-stimulated glucose uptake. 42 , 43 1 H-MR spectroscopy (MRS) quantification of IMCL has shown significant correlations with biochemical and electron microscopic measurements of muscle biopsy samples. 44 1 H-MRS has shown that IMCL is strongly correlated with insulin sensitivity in childhood and is higher in obese adolescents than those of normal body weight. 45 Thus, IMCL accumulation and insulin resistance might be related to the natural course of obesity rather than aging. 45 In healthy adults, IMCL assessed noninvasively by localized 1 H-MRS is a good indicator of whole-body insulin sensitivity. 46 IMCL quantifications using 1 H-MRS distinguish between obese and normal-weight subjects and correlate with body composition and insulin resistance obtained by an oral glucose tolerance test. 47 However, it is important to note that IMCL is not a direct marker of insulin sensitivity, but may reflect accumulation from increased lipolysis, excess dietary fat, or impaired mitochondrial lipid oxidation. 48 Several studies used positron emission tomography (PET) for assessing insulin resistance. 18 Ffluorodeoxyglucose (FDG) PET imaging demonstrated insulin-stimulated FDG uptake in skeletal muscle and whole-body glucose uptake. 49 18 F-FDG PET imaging in skeletal muscle also showed impaired glucose transport in type 2 diabetes and obesity, and impairment of glucose phosphorylation in type 2 diabetes. 50 Because these PET studies used compartmental modeling originally designed for brain studies, 51 dynamic PET imaging has been subsequently developed to acquire imaging following sequential injections of radioactive ligands to track glucose metabolism in skeletal muscle. 52, 53 Dynamic tripletracer PET using 15 O-H2O, 11 C-3-O-methylglucose , and 18 F-FDG quantitatively determined glucose metabolism including delivery, transport, and phosphorylation under insulin-stimulated conditions in lean and healthy volunteers. 54 Dynamic triple-tracer PET demonstrated insulin resistance in patients with type 2 diabetes, demonstrating impairments in glucose transport and phosphorylation in skeletal muscle. 55 Another dynamic PET study discovered that glucose transport defects are strongly correlated with insulin resistance in normal-weight to obese subjects without diabetes, but also found heterogeneity between soleus and tibia anterior muscle in insulin action. 56 Recently, a PET-MR imaging has been proposed for assessing tissue-specific insulin-mediated 18 F-FDG influx rates, tissue depots, and whole-body insulin sensitivity, which enable individualizing comprehensive metabolic phenotypes in subjects. 57 However, although quantitative, the use of PET for this purpose is hampered by its limited availability.
EVALUATING TARGET ORGAN DAMAGE
Heart. MetS is associated with a spectrum of cardiovascular complications. In MetS, activated reninangiotensin-aldosterone and sympathetic nervous systems can lead to elevated heart rates, renal sodium retention, circulating blood volume, ventricular end-diastolic volume, and cardiac output. 58 Elevated heart rate impairs left ventricle (LV) filling and relaxation, increases myocardial oxygen consumption, reduces coronary perfusion, and deteriorates LV function. 59 Increased cardiac output gives rise to LV dilation, higher wall stress, and finally compensatory hypertrophy. A thicker heart is stiffer and may have relaxation abnormalities. This diastolic dysfunction induces left atrium enlargement, leading to atrial arrhythmias. 60 Consequently, diastolic dysfunction in MetS is an early feature and independent predictor of mortality. 61 Indeed, animal studies have demonstrated that heart rate reduction and mineralocorticoid receptor antagonism improve MetS-related LV diastolic dysfunction. 62, 63 Several studies have linked MetS to LVH regardless of gender. 64, 65 Although hypertension was most strongly related to LVH in both men and women, abdominal obesity and hyperinsulinemia were related to LVH only in women. 64 This may imply a gender difference in the mechanisms for development of LVH. Obesity affects LV enddiastolic volume in proportion to BMI, but affects LV mass more than volume. 66 In addition, recent findings have established that most obese subjects develop concentric rather than eccentric LVH. 58, 66 Echocardiography is commonly used for assessing cardiac structure and function because of its low cost, availability, temporal resolution, and feasibility of online analysis. The type and severity of LVH can be established by assessment of relative wall thickness and LV mass index using M-mode echocardiography, although its accuracy and reproducibility are often unsatisfactory. 67 Moreover, echocardiographic images of sufficient quality may be hard to obtain in severely obese subjects. Pulsed tissue Doppler imaging is the reference modality to investigate LV dysfunction in the MetS, 61 in which regional LV function is quantified as the myocardial velocity of long-axis motion during systole (S′), early diastole (E′), and late diastole (A′). 68 The calculation of the E/A ratio and the deceleration time of the E peak filling velocity (DT) are useful indices for diagnosis of diastolic dysfunction. 68 A recent study using tissue Doppler imaging suggested that diastolic dysfunction may develop in patients with MetS even in the absence of hypertension. 69 Strain and strain rate echocardiographic imaging is also sensitive and feasible for detection of subclinical myocardial functional abnormalities in MetS. 70 In strain rate imaging, speckle tracking can assess LV myocardial shortening or strain. MetS is associated with impaired LV circumferential and longitudinal strain assessed by speckle tracking echocardiography, 71, 72 although several studies have shown an impairment only in longitudinal LV strain in early MetS. 73, 74 In addition, strain rate echocardiography imaging has shown impaired LA function, 75 as well as impaired LV systolic and diastolic functions in patients with MetS, even in the presence of normal LV ejection fraction. 76 MRI provides valuable anatomic and functional imaging of the heart. Volume-independent structural measurement using cardiac MRI has been validated using human autopsy and animal specimens. 67 Cine imaging of the beating heart is important for functional cardiac MRI, and cine MR with steady-state free precession is widely accepted as the reference for assessment of ventricular function as well as mass, 77 and allows measurement and monitoring of LV mass index in proportion to weight reduction in MetS. 78 Three-dimensional (3D) volume tracking of the mitral annulus with cine MR is useful for assessing diastolic dysfunction, yielding parameters that correlate with tissue Doppler-based variables. 79 Flow quantification using velocity sensitivity with cardiac MR is also a good technique to quantitatively assess diastolic dysfunction as well as valvular and congenital heart disease, 80 as validated with tissue Doppler imaging. 81 Tagging can be used to measure myocardial strain in 3D. 82 Tagged cardiac MR provides information on regional LV function, which includes the slice distance, cardiac deformation, and torsion (twist normalized by slice distance). 83 In hypertensive individuals, cardiac torsion is elevated, potentially as a compensatory mechanism to maintain an adequate stroke volume and cardiac output in the face of the progressively reduced LV volumes and myocardial shortening. 83 Severely obese adolescents also had increased LV torsional mechanics. 84 In obese animals, stress cardiac MR has shown supranormal values of LV radial strain and torsion early on diet, followed by later deficits, 85 although obese subjects show lower trends of LV twist and torsion. 86 Therefore, torsion changes in MetS might depend on the stage of MetS and timing of scanning. Additionally, the complexity of quantitative analysis limits the use of tagging to the evaluation of the wall motion. 82 Blood oxygen level-dependent (BOLD) MRI can assess myocardial oxygenation using paramagnetic deoxyhemoglobin as an endogenous marker (Fig 2, B) . Increased deoxyhemoglobin accelerates the magnetic spin of neighboring water molecules, and decreases signal intensity on apparent spin-spin relaxation time-weighted (T2*) images. The rate of magnetic spin dephasing, R2*(=1/ T2*), reflects the tissue content of deoxyhemoglobin. 87 Using BOLD-MRI in a swine MetS model, we observed obesity-elicited myocardial hypoxia, 88 but further studies are needed to determine myocardial oxygenation in human subjects with MetS.
Coronary artery atherosclerosis. The association of obesity with atherosclerotic heart disease has been widely known. 58 MetS is associated with presence and severity of coronary atherosclerosis, 89 especially with vulnerable lipid-rich plaques. 90 Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) can assess plaque burden, composition, morphology, and response to therapy, although their use is limited because of the need for invasive intravascular approach. A recent study in patients with MetS and type-2 diabetes has shown that IVUS is useful for diagnosing the degree of coronary artery stenosis, 91 although this may not correlate with the extent of decreased perfusion and metabolism of the affected myocardial territory. OCT use the back-reflection of near-infrared light from optical interfaces in tissue. Although it has a low penetration depth into tissue, OCT can assess plaque morphology with high resolution and thus be used for early diagnosis of coronary artery disease (CAD). 92 Coronary plaques in MetS contain larger lipid assessed by 3-vessel OCT. 92 In addition, rupture of the plaque in myocardial infarction is more frequent in patients with MetS and associated with lower cap thickness measured by OCT. 93 Using CT, coronary artery calcification (coronary calcium score) can serve as an indicator of the presence of atherosclerosis. 94 Coronary CT angiography is a noninvasive diagnostic tool that has high diagnostic performance for both detection and exclusion of CAD. Using coronary CT angiography, patients with MetS showed a higher prevalence, extent, and severity of CAD compared with those in patients without MetS. 95 However, coronary CT angiography has a limited value in assessing the hemodynamics of a given stenosis. Recently, different CT techniques including myocardial CT perfusion imaging have evolved for detection of myocardial ischemia. 96 Various sequences in cardiac MRI can be used in initial workup and follow-up evaluation of CAD in MetS. Firstpass MRI perfusion imaging with exogenous contrast or arterial spin labeling (ASL) MRI evaluate myocardial perfusion and angiogenesis. 97 ASL-MRI uses the water spins of blood as an endogenous tracer. Perfusion is measured by acquiring a set of labeled (tagged) and nonlabeled (control) images 98 without a need for exogenous contrast media, and thus is useful in patients at a high risk groups for adverse effects of contrast. Delayed contrast enhancement MRI can assess the transmural extent of viable myocardium. 99 After administration of gadolinium, scar tissue in the infarcted myocardium shows delayed enhancement. 99 Diffusion MRI assesses cardiac microscopic tissue structure, and diffusion tensor imaging (DTI) can be used for monitoring the process of LV remodeling after myocardial infarction. 97 Myocardial single-photon emission computed tomography (SPECT) with thallium-201 or technetium-99m labeled tracers is commonly used for evaluating myocardial perfusion, viability, and infarct size, as well as ventricular function and intraventricular synchronism. 100, 101 In patients with MetS, stress-induced reductions in myocardial perfusion measured by SPECT provide an accurate information for near-term risk stratification of CAD. 102 PET can also assess myocardial perfusion, metabolism, and viability, 103 but is more expensive and less widely available than SPECT. Semiquantitative measurement using radionuclide cannot quantify myocardial perfusion in patients with multivessel CAD or non-obstructive atherosclerosis. 104 Contrarily, quantification of myocardial blood flow and flow reserve by PET may improve diagnosis and management of CAD. 104 Furthermore, hybrid imaging tools, such as cardiac PET-CT and PET-MRI, provide particularly valuable co-registered anatomic information. They can also be helpful for evaluating myocardial infarction by quantifying both vulnerable plaque burden and myocardial scar tissue. 105 Fat-MR-based PET motion correction imaging has shown promise in evaluating vulnerable coronary plaque. 106 In addition to infarction and viability, PET-MR has potential in various cardiac applications including morphology, LV function, perfusion, and molecular imaging.
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Heart-related fat. Peri-and intra-cardiac fat is elevated in MetS. 108 It is composed of myocardial and pericardial fat, subdivided into epicardial and paracardial fat according to deposition inside or outside pericardium. 109, 110 For assessing myocardial fat in vivo, 1 H-MRS has proven to be a reliable method in humans.
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Although myocardial triglyceride content associates with LV diastolic dysfunction in diabetes, 112, 113 it is not independently related to MetS, thus seeming to have a more complex role. 108 Increased pericardial fat, on the other hand, is associated with the severity of structural and functional alterations of the heart in MetS, 108 including coronary artery calcification, 114 LV diastolic function, 108 cardiac output, and stroke volume. 115 It has been suggested that epicardial fat is a source of inflammatory mediators, 116 and paracardial fat may exert a restrictive pressure on myocardial diastolic expansion. 110 Pericardial fat can be assessed with echocardiography, CT, and MRI. Echocardiographic assessment measuring linear pericardial lipid thickness could be easy and effective, but 3D volumetric methods using CT and MRI offer higher reproducibility. In echocardiography, epicardial fat thickness appears as an echo-free space that can be measured on the free wall of the right ventricle from both parasternal long-and short-axis views. 117 This method showed a strong correlation with MRI-based assessments. 117 Additionally, epicardial adipose tissue measured by echocardiography was related to components of MetS. 118 CT coronary angiogram studies after contrast administration show infiltrating epicardial fat as low-density deposits. 119 In MRI, electrocardiographically gated steady-state free-precession short axis cine sequences can measure pericardial fat as well as ventricular function. Manual contour tracing segmentation can be used for image-based volumetric quantification. 115 For separating the different pericardial fat, fat-selective imaging is necessary. 120 These quantitative assessments of pericardial fat using MRIbased volumetric approach are feasible and reproducible, although somewhat laborious.
Peripheral vessels. Hyperglycemia and insulin resistance in MetS decrease production of nitric oxide and promote production of endothelin-1, which cause endothelial dysfunction. 121 In addition to insulin, increased leptin and free fatty acids may increase sympathetic activity and its influence over the vascular system, 122 and vascular smooth muscle cells have blunted vasodilatory responsiveness in MetS. 121 Finally, MetS exacerbates arterial aging, stiffness, and atherosclerosis. 123 Vascular stiffness can be indexed as pulse wave velocity (PWV), defined as the velocity of the systolic pressure waves propagating along the vessels. 124 A higher PWV reflects lower vessel distensibility and higher vascular stiffness, 124 and is aggravated in MetS, regardless of age and sex. 125 Applanation tonometry and US are common clinical methods for estimating global PWV by measuring distance and the temporal shift between the carotid and the femoral pressure waveforms. 126 However, they cannot assess the ascending aorta or provide regional information, and distance measurements used in the PWV calculations can be inaccurate. 126 Additionally, the vessels may have different mechanical and functional characteristics depending on position, aging, and disease. 127 Therefore, local or regional PWV has been analyzed by echo-tracking, US, or MRI. MRI can inform simultaneously on cardiac function, aortic geometry (diameter and arch length, widening, and curvature), and pliability (distensibility, compliance, elastic modulus, and stiffness index). 128 Velocity-encoding MRI provides the blood flow velocity by direct imaging of the thoracic and abdominal aorta. This direct measurement of the path length of pulse waves enables to evaluate local or regional PWV in specific vascular segments, as well as global PWV even in the presence of a tortuous vessel. 124 The distance between measurement sites can be manually or semiautomatically assessed, and the transit time for wave propagation can be automatically determined using time-flow or time-velocity curves. 80 A recent study demonstrated the association between the presence of MetS and increased carotid PWV using MRI for local PWV in middle-aged subjects. 129 Perivascular adipose tissue regulates vascular function through paracrine effects 130 and may directly boost vascular stiffness. Multidetector CT, MRI, and 1 H-MRS can quantify perivascular lipid volume. 115, 131 Interestingly, periaortic adipose tissue measured by 1 H-MRS is not related to insulin resistance in MetS. 115 Similarly, in obese children, no association was found between CIMT and insulin resistance, 132 although CIMT was correlated with other components of MetS, especially increased BP. 132 MetS is associated with newly developed carotid plaque, and thus with progression of early atherosclerosis. 133 Chronic inflammation in MetS may precipitate atherosclerosis and accelerate acute thrombotic complications. 134 Therefore, identifying the plaque characteristics using imaging modalities may help direct interventions in atherosclerosis with MetS. CIMT assessed using high-resolution B-mode US detects increased CIMT >1 mm, 135 but cannot provide information about the biology of the plaque. Using microbubbles filled with inert gas, contrast-enhanced US identifies microvasculature within the carotid plaque that are associated with plaque rupture, 136 and IVUS and OCT also allow analyzing the carotid plaque. 137, 138 CT enables detecting calcium in the arterial wall and differentiating lipidrich from fibrous plaque, but is limited by ionizing radiation. 136 MRI might be the most promising method for studying atherothrombotic disease in humans in vivo. 139 MRI provides information on the plaque volume and composition including lipid core, fibrosis, calcification, and intraplaque hemorrhage deposits. 139 Vascular inflammation present in some atherosclerotic plaques can be evaluated by 18 F-FDG-PET. 140 High FDG uptake can identify the plaque rich in macrophages, which indicate vulnerability in carotid atherosclerosis. MetS is associated with increased FDG uptake, suggesting increased inflammation.
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Kidney. MetS increases the risk of renal insufficiency and microalbuminuria. 142 Potential mechanisms in kidney of MetS include insulin resistance and adipose tissue expansion. Adipose tissue expansion elicits oxidative stress, chronic inflammation, and exacerbation of insulin resistance, which lead to endothelial dysfunction, activation of renin-angiotensin-aldosterone system, and hypertension. 143 Elevated aldosterone levels promote sodium reabsorption, and in turn, induce the rise in glomerular filtration rate (GFR) through tubuloglomerular feedback. 143 Thus, early MetS induces renal hyperperfusion and glomerular hyperfiltration. However, sustained hyperfiltration burdens glomerular capillaries, and microvascular loss is eventually incurred. 143 A recent systematic review of literature has also described the association of MetS with kidney stone disease. 144 Kidney stones in obese patients are generally composed of calcium oxalate and uric acid. 145 Insulin resistance decreases renal ammoniagenesis and activity of Na+/H+ exchange channel, and finally causes inappropriate acid urine, which plays an important role in stone formation. 146 Renal US parameters include renal length, renal cortical echogenicity, or distinctness of the corticomedullary boundary. 147 Doppler US is a useful noninvasive imaging to measure pulsatility and resistive indices for detecting alterations in renal vascular resistance, 148 which is increased in subjects with early MetS, 148 indicating renal vasoconstriction and microvascular remodeling. 143 Renal imaging using radionuclide scintigraphy is infrequently used because of the need for an exogenous radioactive tracer, low spatial resolution, and development of alternative imaging modalities. 149 Notwithstanding, the study in patients who underwent renal transplantation showed that MetS was associated with GFR decline assessed by urinary clearance of 99mTc-DTPA. 150 CT allows accurate and noninvasive evaluation of renal structure and function including kidney volume, vascular volume fraction, regional perfusion, renal blood flow, GFR, and tubular function. In dynamic CT analysis, regions of interest and time-attenuation curves are used to obtain measures of renal blood flow and GFR. 151 In our swine study using multidetector CT, early MetS has shown increased GFR and renal cortical perfusion, associated with renal adiposity and microvascular proliferation. 152 CT has high spatial and temporal resolution, but is limited by radiation exposure and risk for contrast-induced nephropathy, especially in patients with chronic kidney disease. 153 Renal perfusion can also be measured by dynamic contrast-enhanced (DCE)-MRI and ASL-MRI. DCE-MRI uses exogenous tracers like gadolinium-chelates. DCE-MRI also can estimate single-kidney GFR using multi-compartmental models, although a reference standard needs to be established. 98 However, gadoliniumbased contrast may have a rare but critical adverse effect, nephrogenic systemic fibrosis, particularly in patients with renal insufficiency. 154 In patients with MetS, renal perfusion of a single coronal kidney slice by ASL-MRI was related with renal plasma flow directly measured by paraaminohippuric acid plasma clearance. 155 Furthermore, ASL-MRI enables to approximate changes in kidney perfusion after pharmacological intervention. 155 On the other hand, it does not provide estimates of GFR.
Diffusion-weighted imaging (DWI) allows quantification of water molecule movement, which is restricted in a structured environment and not equal in all directions (anisotropic). 156 The average diffusivity of water molecules is quantitated by the apparent diffusion coefficient, and has been proposed to reflect fibrosis. Recently, DWI has been applied for assessing the severity of renal pathology in chronic kidney disease. 157 However, interpretation of DWI may require special attention in MetS, because renal adiposity confounds calculation of DWI parameters and may lead to underestimation of renal diffusion and pseudodiffusion even at low fractions of the fat signal. 158 BOLD-MRI has demonstrated renal medullary hypoxia in patients with stage 3 diabetic nephropathy. 159 Contrarily, we have found that both cortical and medullary oxygenation is preserved in pigs with early MetS, suggesting that renal oxygenation decreases in more advanced disease. 152 BOLD-MRI is a noninvasive and promising method for evaluating renal oxygenation, but renal anemia, systemic acid-base disorders, deoxyhemoglobin-tototal hemoglobin ratio, partial pressure of oxygen in veins, and tissue oxygen levels may interfere with accurate interpretation of BOLD-MRI.
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Kidney-related fat. Para-renal, perirenal, and renal sinus fat accumulation may increase intrarenal pressures, sodium reabsorption, and hypertension via activation of the renin-angiotensin-aldosterone system. 143, 161 Perirenal fat thickness is an independent predictor of kidney dysfunction in subjects with type-2 diabetes, 162 and can exert paracrine effects on the renal circulation through proinflammatory cytokines. We have demonstrated that in pigs with early MetS perirenal fat directly leads to renal artery endothelial dysfunction, partly mediated by tumor necrosis factor-α. 163 Doppler US can be used for measuring para-and perirenal fat from the inner side of the abdominal musculature to the surface of the kidney. In obese subjects, para-and perirenal US fat thickness positively correlates with 24-hour aldosterone urine concentrations and diastolic BP. 164 US measurements of para-or perirenal fat thickness show a good correlation with CT assessments (r = 0.76). 162 Renal sinus and perirenal fat in CT can be separated from kidney and other organs based on the attenuation range for fat (Fig 2, C) , and CT perirenal fat thickness was demonstrated as a reliable estimate of perirenal fat mass. 165 Perirenal fat can be also expressed as a ratio to the volume of the corresponding kidney. 152 Importantly, MR can also be used for quantifying intra-renal fat content. A recent study found increased renal lipids in subjects with type-2 diabetes using Dixon-based MRI, 166 although renal fat fraction is estimated at 0.8% in healthy subjects and only 2.38% in type 2 diabetes. 166 MR measured renal sinus fat and intra-renal fat has shown a relation with weight loss in subjects with abdominal obesity. 167 In addition, 1 H-MRS enables metabolic imaging for detection of cortical triglycerides in human kidneys.
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Liver. An increase in liver fat is frequently observed in MetS and considered a phenotype of MetS because of its correlation with insulin resistance, dyslipidemia, and obesity. 169, 170 Hepatic steatosis (>5%-10% fat) because of non-alcoholic causes is called non-alcoholic fatty liver disease (NAFLD). MetS is also an important predictor of non-alcoholic steatohepatitis (NASH) and hepatic fibrosis. 171, 172 In MetS, lipolysis in excessive visceral adipose tissue can increase non-esterified fatty acids, which run into the liver. 171 Adipose tissue can become hypoxic and has increased macrophage infiltration, proinflammatory cytokines, and decreased adiponectin. This inflamed adipose tissue is insulin resistant and promotes synthesis of intrahepatocellular tyiglycerides and very low-density lipoprotein.
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NAFLD. In US, the echogenicity of the normal liver is similar to those of the right kidney and spleen, whereas NAFLD has higher echogenicity using conventional B-mode US. Although US is cheap and easily available, it has low sensitivity for mild to moderate steatosis and a limitation in distinguishing fibrosis and NASH from steatosis. 173 CT enables quantification of hepatic steatosis by determining the difference and ratio between the attenuation values of liver (normal: 50-65 HU, cutoff for steatosis < 48 HU) and spleen (normal: 8-10 HU lower than a liver). 119 On noncontrast CT, 30% steatosis on mi-croscopy correlates to the findings of hepatic to splenic attenuation ratio less than 0.8 and difference of −10 HU.
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On contrast-enhanced CT, hepatic steatosis can be also diagnosed, with hepatic to splenic attenuations difference of −20 to −25 HU. 119 Although CT shows high specificity for hepatic steatosis in subjects with MetS, 15 it has low sensitivity and is unable to distinguish fibrosis and NASH from steatosis. MRI and 1 H-MRS seem to be the most accurate techniques to evaluate hepatic steatosis, 175 and are also reliable compared with liver histology in NAFLD. 176 One of the MRI methods is modified Dixon, based on chemical shift fast gradient between water and fat. It can detect a hepatic fat fraction as low as 15%, and compensate for T2* effect caused by the relatively high iron content in the liver. 119 Hepatic fat measured by this method exhibits a good correlation with 1 H-MRS. 177 Fat-selective spectral-spatial gradient echo imaging combines chemical shift selectivity with simultaneous slice-selective excitation in gradient-echo imaging sequences, and can also determine hepatic fat fraction. 178 MRI-proton density fat fraction has been suggested as a good biomarker for steatosis, as it strongly correlates with histologic grading of steatosis. [179] [180] [181] In 1 H-MRS, hepatic steatosis can be diagnosed when normally high water peak at 4.2 ppm is decreased and lipid peak at 0.9-2.2 ppm is markedly elevated.
Inflammation and NASH. NASH is histologically characterized by ballooning necrosis near steatotic hepatocytes, mild inflammation, and possibly fibrosis. 172 Conventional imaging modalities have limitations to distinguish between NAFLD and NASH and stratify the severity of NASH. A newer technique to differentiate NAFLD and NASH, phosphorus-31 ( 31 P) MRS, assesses the ratios of various phosphorus-containing metabolites, including cell membrane precursors (phosphomonoesters), degradation products (phosphodiesters), and nicotinamide adenine dinucleotide phosphate. 182, 183 In a recent study, 31 P-MRS has shown distinct biochemical changes in different NAFLD states and a good diagnostic accuracy for NASH.
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Fibrosis and cirrhosis. NAFLD in MetS has potential to progress to NASH, advanced fibrosis, and cirrhosis because of lipotoxicity and activation of inflammatory and fibrogenic pathways. 185 Hepatic fibrosis is accumulation of excessive collagen fibers responding to chronic inflammation and hepatocyte injury. Existing morphologic assessment on US, CT, and MRI could be subjective and unreliable for detecting early stages of fibrosis. Newer imaging techniques have been used to diagnose liver fibrosis and include US elastography (transient elastography, shear wave elastography, or acoustic radiation force impulse imaging) and magnetic resonance elastography (MRE). 186 US elastography measures the velocity of acoustically induced mechanical shear waves traveling through the liver, which increases in fibrotic livers. However, US elastography may be influenced by inflammation, 187 extrahepatic cholestasis, 188 and central venous pressure, 189 and have limitations in patients of high BMI, ascites, or narrow intercostal space.
190 MRE, the current gold standard for diagnosis and staging of liver fibrosis especially in obese patients, uses continuously generated low frequency mechanical waves in tissue from the vibration source placed on the body surface. 191 Phase contrast MRI technique gets wave images by micronlevel cyclic displacement. Then, these wave images are automatically processed to produce quantitative images about the stiffness of tissue. 191 MRE has shown a strong correlation with the histologic fibrosis score as well as interrater reliability in many studies. [192] [193] [194] However, hepatic MRI signal waves may not be visualized in patients with marked iron deposition, and availability remains comparatively limited. 190 Indeed, many noninvasive imaging techniques that await clinical translation include MRI (DWI, hepatobiliary contrast agents, perfusion, and quantitative T1, T2, T1 rho mapping), CT (perfusion, fractional extracellular space, and dual energy), contrast-enhanced US, texture analysis, and direct molecular imaging probes of collagen.
186
Pancreas. MetS is associated with non-alcoholic fatty pancreatic disease (NAFPD). 195 Fat accumulation in pancreas is usually diffuse but can be uneven, showing mainly fat replacement in pancreatic head. 196 In contrast to liver, NAFPD histologically spares cells and accumulates adipocytes within the pancreatic interstitial septa. 197 Yet intracellular triglyceride accumulation observed in animal studies may precede adipocytes infiltration. 198, 199 NAFPD can be assessed using US, CT, MR, and MRS. Applications of US might be endoscopic or transabdominal US, although it is limited by digestive interposition and operators. In US, NAFPD can be assessed through an increase in echogenicity of the pancreatic body compared with the kidney, 195 or in endoscopic US with retroperitoneal fat. 200 A recent study using transabdominal US has shown that NAFPD was associated with each component of MetS. 195 However, fibrotic pancreas is also hyperchogenic in US, and therefore CT or MRI should be used to confirm NAFPD. 201 In CT, NAFPD shows hypodense pancreas with low HU compared with the spleen 202 and lobules of acini surrounded by macroscopic fat. 119 CT attenuation index between pancreas and spleen was validated with pancreatic fat fraction in histology. 203 In MRI, the modified Dixon exhibits a good correlation with 1 H-MRS for assessment of pancreatic fat fraction. 177 Fat-selective spectral-spatial gradient echo imaging can also determine pancreatic fat fraction. 178 Recently, a fat-water 3D imaging technique called IDEAL (Iterative Decomposition with Echo Asymmetry and Least squares estimation) accurately characterized the proportion of fat and water content, and might be better suited for fat quantification in the pancreas compared with MRS. 204 Finally, 1 H-MRS can be also used for measuring pancreatic triglyceride content. 205 Increasing evidence support the role of pancreatic fat in the development of type 2 diabetes, although its pathogenesis still remains undetermined. Some studies, but not all, 206 have shown the correlation between MetS and hyperglycemia or β-cell dysfunction. 195, 198, 205 Thus, whether fatty pancreas has predictive value for diabetes needs further investigation.
Brain. MetS is known to raise the risk of cognitive dysfunction and dementia 207 as well as ischemic stroke. 208 The mechanisms underlying brain complications in MetS are likely to be associated with hyperglycemia, insulin resistance, arterial hypertension, and vascular lesions. Hyperglycemia produces free radical, glycation end products, and oxidized lipids, which can give rise to neurodegeneration. 209 Insulin resistance induces prolonged peripheral hyperinsulinemia, downregulated bloodbrain barrier insulin receptors, and decreased insulin transport to the brain. This insulin dysregulation decreases cerebral glucose metabolism, neurogenesis, and repair, and increases inflammation, oxidative stress, and vascular dysfunction.
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Cognitive impairment and dementia. Conventional structural MRI is the most widely used modality for evaluating the brain although brain macrostructure was not associated with MetS, 211 or correlated with cognition impairment in subjects with MetS. 209 However, microstructural white matter abnormalities in MetS might be the underlying mechanisms of cognitive impairment. 212 Early changes on brain microstructure can be assessed using MRI technique like DTI and magnetizationtransfer imaging (MTI). DTI measures water diffusion in the intracellular cytoplasm along the axons, whereas MTI assesses the magnetization exchange between protons bound to water and to macromolecules like the myelin lipids and proteins. 213 Studies using DTI or MTI have shown microstructural white matter changes in MetS. 211, 212, 214, 215 Additionally, the area with impaired white matter integrity in MetS is correlated with verbal learning and memory processing, 211, 212 and components of MetS were independent factors in brain tissue integrity. 211 Using functional neuroimaging, patients with MetS showed a lower BOLD signal coinciding with development of cognitive impairment. 216 18 F-FDG PET suggests effects of insulin dysregulation on the brain glucose metabolism in patients with MetS. 217 Measurements of regional cerebral glucose metabolism using 18 F-FDG PET can also support the clinical diagnosis for cognitive impairment and dementia, 218 although the association between MetS severity and regional hypometabolic changes in 18 F-FDG PET at the very early stage of cognitive decline still remains to be clarified. 219 Studies of the correlation between cognitive dysfunction in MetS and functional changes in brain activity are limited. Vascular dementia represents diverse but nonspecific abnormalities.
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Ischemic stroke. Previous studies have shown that MetS is an important risk factor for intracranial atherosclerotic stroke, 221 acute ischemic stroke, 222 and minor ischemic stroke. 145 In acute ischemic stroke with MetS, inflammation and arterial stiffness play a role, 222 thus PWV measurement could be helpful for assessing these patients. In addition to conventional CT, MRI, and their angiography, new techniques including vessel wall MRI, transcranial Doppler (TCD), 4D CT angiography, and MR angiography have been widely used for diagnosis of acute ischemic stroke. 223 MetS is associated with lower cerebral vasomotor reactivity, a predictor of increased risk of ischemic stroke. 224 TCD evaluates the intracranial arterial vessels and the cerebral blood flow velocity by placing a low-frequency transducer on the scalp. 225 In addition, TCD is a cost-effective and readily repeatable diagnostic imaging test characterized by high sensitivity and specificity for cerebral artery occlusion.
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PRACTICAL AND THERAPEUTIC APPROACHES
Imaging modalities have markedly advanced, yet indications of their use in MetS have not been fully established in clinical settings. Evaluation of abdominal obesity and insulin resistance is necessary for assessing severity of MetS. A single-slice CT scan at L4 level in late expiration can be the reference for assessing SAT and VAT, given its accuracy, reproducibility, repeatability, and convenience, allowing follow-up monitoring. For simultaneous evaluation of cardiovascular risk factors, MRI is a good choice for fat assessment. A common method to assess insulin resistance is the homeostatic model assessment, an indirect calculation based on glucose and insulin levels, yet MRS or PET can provide greater insight for better understanding of the pathogenesis. Fig 3 shows a potential diagnostic algorithm based on this review.
It is important to decrease their risk for development of type 2 diabetes and cardiovascular disease in subjects with MetS. Treatment includes life style modification, pharmacological therapy of atherogenic dyslipidemia, hypertension, and hyperglycemia, and possibly surgical approaches. Weight reduction and exercise with patient motivation and adherence is effective. 226 Targets for dyslipidemia in MetS are lowering low-density lipoprotein cholesterols using statins with or without ezetimibe 227 and triglycerides by fibrates or niacin. 228 To control BP, angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists are considered as first-line therapy, because of their favorable metabolic profile. 229, 230 In sub-jects with insulin resistance, metformin can help prevent progression to diabetes, although lifestyle modification may be more effective. 231 Bariatric surgery is also a useful option in patients with severe obesity and cardiovascular comorbidity.
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CONCLUSION
MetS leads to increased morbidity and mortality. In early stages of MetS, deleterious changes in each target organ often are subclinical and possibly reversible. Imaging modalities are helpful to stratify risk factors, including abdominal obesity and insulin resistance, and evaluate target organ damages in individual patients with MetS (Fig 1) . Noninvasive diagnostic imaging modalities that have been frequently used for this purpose, such as US, CT, and MR, have advantages and limitations. US is a safe, relatively economical, and easily applicable diagnostic tool, but lacks standardized and reproducible methods, and requires experienced operators and considerable skill. CT is faster and less costly than MR, and feasible in patients with some implantable medical devices. However, it is sometimes less sensitive and limited by ionizing radiation. MR offers the advantage of no radiation exposure, and is thus preferable to children and patients requiring simultaneous evaluation of multiple risk factors. In addition, it enables a greater range of soft tissue contrast, as well as more detailed and quantitative studies of anatomy and function. Nevertheless, MR incurs a higher cost. Nuclear imaging can also investigate target organ function, but is hampered by its limited availability, high cost, and radiation exposure. Conceivably, a combination of techniques might be most useful to illustrate the entire spectrum of alterations associated with MetS, although the cost-effectiveness of this approach remains to be determined. Overall, imaging studies in MetS may help diagnosis, predict target organ injuries, and develop novel therapeutic target to alleviate and avert them.
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